Web/Tech

Later this year, a nice review of the current state of digital pathology, how we got here and where the technology will take us in the future will be released by Springer. My personal thanks to the publisher and our editors for their support...

Webinar: New Study on NSCLC published – Join the discussion The discovery and clinical application of molecular biomarkers in solid tumors, increasingly relies on nucleic acid extraction from FFPE tissue sections and subsequent molecular...

A national digital molecular pathology research programme led by the Belfast Cancer Research UK (CRUK) Center has been awarded the highly competitive CRUK Accelerator Award. Using PathXL software, this programme will link a number of major UK...

Investors include ResMed founder Peter Farrell and Prairie Ventures Mikroscan Technologies, maker of brightfield remote telemicroscopy systems, has closed on $3M in additional funding from a group of private investors including Peter...

PathXL today announced the publication of research demonstrating that TissueMark, the company's automated tumor analysis platform, can bring reproducibility and accuracy to molecular diagnostics in lung cancer. The results come from a...

With the introduction of bundled payments, telepathology consults can greatly reduce the risk of unreimbursed tests. SPOT Imaging’s Philip Merlo explains. By Phillip Merlo, VP-Digital Pathology Systems SPOT Imaging Bundled payments...